Apellis Pharmaceuticals Analyst Ratings
Benzinga14:20 ET
Buy Rating Affirmed for Apellis Pharmaceuticals Amid Positive Outlook and Growth Potential
TipRanksApr 26 11:45 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Apellis Pharmaceuticals (APLS), Quest Diagnostics (DGX) and Healthcare Services (HCSG)
TipRanksApr 26 03:08 ET
Impact of Izervay's Growth on Apellis Pharmaceuticals: Maintaining a Hold Rating Amidst Rising Competition
TipRanksApr 26 02:24 ET
Apellis Pharmaceuticals Analyst Ratings
BenzingaApr 25 13:13 ET
Maintaining Market Dominance: Strong Buy Rating on Apellis Pharmaceuticals With a Target Price of $85
TipRanksApr 25 10:15 ET
Wells Fargo Remains a Hold on Apellis Pharmaceuticals (APLS)
TipRanksApr 18 06:45 ET
Analysts Conflicted on These Healthcare Names: Enliven Therapeutics (ELVN), Alkermes (ALKS) and Apellis Pharmaceuticals (APLS)
TipRanksApr 18 01:10 ET
Apellis Pharmaceuticals Analyst Ratings
BenzingaApr 17 12:24 ET
Wedbush Maintains Neutral on Apellis Pharmaceuticals, Lowers Price Target to $57
BenzingaApr 17 12:26 ET
Apellis Pharmaceuticals Analyst Ratings
BenzingaApr 15 07:05 ET
Analysts Offer Insights on Healthcare Companies: Aslan Pharmaceuticals (ASLN), Rewalk Robotics (LFWD) and Apellis Pharmaceuticals (APLS)
TipRanksApr 15 06:20 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE), Apellis Pharmaceuticals (APLS) and ACADIA Pharmaceuticals (ACAD)
TipRanksApr 9 06:40 ET
Apellis Pharmaceuticals Analyst Ratings
BenzingaApr 9 06:25 ET
Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS) and Bluebird Bio (BLUE)
TipRanksMar 29 04:20 ET
Apellis Pharmaceuticals Analyst Ratings
BenzingaMar 27 13:17 ET
Analysts Offer Insights on Healthcare Companies: EFFECTOR Therapeutics (EFTR), Apellis Pharmaceuticals (APLS) and Ultragenyx Pharmaceutical (RARE)
TipRanksMar 19 07:10 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Laboratory (LH), Apellis Pharmaceuticals (APLS) and Iovance Biotherapeutics (IOVA)
TipRanksMar 7 00:00 ET
Apellis Pharmaceuticals Analyst Ratings
BenzingaMar 6 10:40 ET
Apellis Pharmaceuticals Analyst Ratings
BenzingaMar 4 09:48 ET
No Data
No Data